Grab and OpenAI bring practical AI skills to Southeast Asia

Artificial intelligence has become a major focus for healthcare innovation, from clinical documentation to patient engagement. However, for startups in Southeast Asia, simply having a powerful AI model may not be enough to build a successful business. The real challenge lies in making technology work within existing healthcare environments, which are complex networks of patients, clinicians, hospitals, laboratories, pharmacies, insurers, medical devices, regulations, and software systems.

Understanding these connections can greatly increase the chances of turning a promising pilot into a widely adopted product. Southeast Asia offers significant opportunities for digital health innovation due to growing demand, ageing populations, chronic disease burdens, uneven access to specialists, and disparities between urban and rural healthcare.

Telehealth, remote monitoring, AI support for data-intensive clinical work, and digital platforms to simplify patient journeys can all help address these challenges. Yet, Southeast Asia should not be considered a homogeneous healthcare market. Different countries have varying infrastructure, regulations, digital maturity, reimbursement models, and patient behaviour.

This means that a successful product in one market may not always work well in another without significant localisation beyond just translating the interface. The true challenge often lies not with technology but with workflow integration. For example, an AI system may accurately identify clinically relevant patterns in patient information, but if it cannot access the right information from the hospital's existing software, appear where clinicians work, or be properly recorded and moved to another system without manual input, it may become an isolated tool rather than a valuable addition to the care process.

Clinicians often work under time pressure, so adding another login, dashboard, or manual process could create new operational burdens. Effective healthcare technology should seamlessly fit into how care is delivered, requiring founders to deeply understand the environment surrounding their product. Interoperability, or the ability of different healthcare systems to communicate effectively, is becoming crucial.

A digital health product may need to exchange information with electronic health records, laboratory systems, pharmacy platforms, medical devices, payer systems, or other applications. If these systems cannot communicate well, users may re-enter information, clinicians may switch between applications, patient records may become fragmented, and automation could stop halfway through a workflow.

For startups, interoperability affects usability, adoption, and scalability. Standards-based approaches can help, but supporting technical standards alone is not enough. Founders must also understand how information moves through real healthcare processes and where their product fits within those processes. Instead of viewing AI as a standalone solution, startups can design it around healthcare professionals, using it to prepare information for professional review rather than treating generated content as final.

Decision-support systems can surface relevant information while leaving clinical judgement with the responsible professional. This approach builds trust, which is essential for a young healthcare company. While the idea of autonomous healthcare may be dramatic, it is less valuable than creating trust in the technology. Early architecture decisions can also determine a startup's success.

A product initially designed for a single clinic or hospital department may need to support multiple organisations, new integrations, larger datasets, and different regulatory environments in the future. Founders need to consider these infrastructure implications from the beginning.